The Discovery of N -((2 H -Tetrazol-5-yl)methyl)-4-(( R )-1-((5 r ,8 R )-8-( tert -butyl)-3-(3,5-dichlorophenyl)-2-oxo-1,4-diazaspiro[4.5]dec-3-en-1-yl)-4,4-dimethylpentyl)benzamide (SCH 900822): A Potent and Selective Glucagon Receptor Antagonist
β Scribed by DeMong, Duane; Dai, Xing; Hwa, Joyce; Miller, Michael; Lin, Sue-Ing; Kang, Ling; Stamford, Andrew; Greenlee, William; Yu, Wensheng; Wong, Michael; Lavey, Brian; Kozlowski, Joseph; Zhou, Guowei; Yang, De-Yi; Patel, Bhuneshwari; Soriano, Aileen; Zhai, Ying; Sondey, Christopher; Zhang, Hongtao; Lachowicz, Jean; Grotz, Diane; Cox, Kathleen; Morrison, Richard; Andreani, Teresa; Cao, Yang; Liang, Mark; Meng, Tao; McNamara, Paul; Wong, Jesse; Bradley, Prudence; Feng, Kung-I; Belani, Jitendra; Chen, Ping; Dai, Peng; Gauuan, Jolicia; Lin, Peishan; Zhao, He
- Book ID
- 126494353
- Publisher
- American Chemical Society
- Year
- 2014
- Tongue
- English
- Weight
- 529 KB
- Volume
- 57
- Category
- Article
- ISSN
- 0022-2623
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract 2βPropylβ8βoxoβ1β[(2β²β(1Hβtetrazoleβ5βyl) biphenylβ4βyl)methyl]β4, 5, 6, 7βtetrahydrocyclohept imidazole (KT3β671), which has been found to be a potent and selective angiotesin II receptor antagonist, was synthesized in ^14^Cβlabelled form by using potassium[^14^C]βcyanide. [^14^C](KT3β